You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 8, August 27, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Renal Diseases
 •Acute Renal Failure
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antihyperglycemic Therapy for Patients With Renal Failure

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their Clinical Applications article about the initial dose of a basal-prandial insulin regimen, Drs DeWitt and Dugdale1 did not mention the importance of assessing renal function. Insulin duration of action is increased in renal insufficiency as a result of decreased renal insulin degradation and clearance.2 In addition, renal gluconeogenesis may be impaired, possibly due to limitation of the amino acid substrate alanine.3 Furthermore, many patients with renal failure have decreased caloric intake due to the accompanying anorexia. Indeed, insulin therapy and renal dysfunction have been reported to be the 2 most frequent diagnoses associated with hypoglycemia in hospitalized patients.4 Unfortunately, similar data from outpatients are lacking, in part because of exclusion of patients with various degrees of renal failure from diabetes clinical trials.

In our experience, renal insufficiency is an important factor that predisposes patients with diabetes to iatrogenic hypoglycemia. This is true in those receiving . . . [Full Text of this Article]

Nasser Mikhail, MD, MSc
Endocrinology Division

Dennis Cope, MD
Medicine Department
Olive-View-UCLA Medical Center
Sylmar, Calif



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Antihyperglycemic Therapy for Patients With Renal Failure—Reply
Dawn E. DeWitt and David C. Dugdale
JAMA. 2003;290(8):1027.
EXTRACT | FULL TEXT  

Using New Insulin Strategies in the Outpatient Treatment of Diabetes: Clinical Applications
Dawn E. DeWitt and David C. Dugdale
JAMA. 2003;289(17):2265-2269.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.